Repurchase of shares March 17th

On 17/3 2009, ContextVision AB acquired 25 000 shares. This repurchase of shares is in accordance with the authorisation given by the Annual General Meeting on 5th June 2008. The shares have been bought on the Oslo Stock Exchange at an average price of NOK 28 per share. After these repurchases, ContextVision AB owns a total of 511,700 of its own shares, corresponding to 7% of the outstanding number of shares in ContextVision AB. For inquires please contact
Henrik Bergentoft
Chief Financial Officer
henrik.bergentoft@contextvision.se
+46 (0)8 750 35 52

About Us

ContextVision is the leading independent developer in medical imaging enhancement, analysis and processing technologies, serving leading OEMs and distributors for more than 25 years. ContextVision’s embedded imaging software is relied upon daily by thousands of users around the globe. ContextVision’s patented GOP algorithm allows unprecedented image quality to be achieved by simultaneously enhancing fine structure while reducing noise and speckle across MRI, X-Ray, Ultrasound, CT, and IR. ContextVision’s technology enables the company’s customers to provide superior digital imaging quality to hospitals and clinicians. Such solutions promise more rapid and accurate diagnoses, reduced operator eye fatigue, and ultimately, a greater return-on-investment for medical imaging users. For more information, please visit www.contextvision.com.